StonvexLoading…
StonvexStonvexStonvexCore line items from CLST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $13.90M | $13.86M | $9.66M | $8.01M |
Operating Income | $2.50M | $-3.98M | $587.00K | $159.00K |
Net Income | $2.05M | $-3.09M | $526.00K | $180.00K |
EPS (Diluted) | $0.56 | $-0.78 | $0.12 | $0.04 |
Total Assets | $282.93M | $276.70M | $270.93M | $263.36M |
Total Liabilities | $201.20M | $196.49M | $186.37M | $174.85M |
Cash & Equivalents | $25.20M | $44.30M | $19.01M | $13.47M |
Free Cash Flow OCF − CapEx | $3.10M | $2.74M | $1.84M | $520.00K |
Shares Outstanding | 4.07M | 4.28M | 4.76M | 5.29M |